The hottest Health Technology Substack posts right now

Health tech investments are on the rise, driven by several key venture capitalists leading major deals.
There is growing interest in AI platforms for healthcare, with tech companies promoting responsible implementation.
Many older Americans are skeptical about trusting health information that comes from AI sources.

Spatial medicine is a new field that combines biology and healthcare, focusing on using spatial data to improve patient treatment. This means doctors can analyze cells and tissues in detail to better understand diseases.
Recent research showed that a new treatment using JAK inhibitors was effective for patients with toxic epidermal necrolysis, a serious skin condition. This treatment worked quickly and with no side effects, showcasing the potential of spatial medicine.
The integration of AI and deep learning plays a key role in spatial medicine, helping to analyze complex data and improve patient outcomes. This advancement could lead to more personalized and effective treatments in the future.

Waltz is working on making prescription care cheaper and easier using AI technology. They aim to help consumers make better choices about their healthcare.
There's a growing gap between what virtual health services offer and what people want. This disconnect could affect how healthcare evolves in the future.
Health tech startups are facing challenges after a surge in funding during the pandemic. Many may need to merge or consolidate to survive in the changing market.

Daniel MacArthur is working on making genomic medicine fairer for all communities. His research includes studying genetic differences in underrepresented groups to improve health outcomes.
He believes that funding for science needs to be more flexible and stable. This would allow researchers to take risks and pursue long-term projects without the constant pressure of grant deadlines.
MacArthur thinks research organizations should be built specifically to support scientific work. Many current institutions are not designed for research, making it harder for scientists to succeed.

Stay updated on digital health news with a curated list of top links each week.
Learn about key industry trends like digital health statistics and healthcare transformation by powerful women.
Keep an eye on companies like CVS, Google, and J&J for health industry developments.

Get a weekly roundup of the best Substack posts, by hacker news affinity:

N-of-1 trials focus on understanding individual patient responses to interventions.
N-of-1 trials are valuable for rare diseases, chronic pain, and long-term treatments.
Using N-of-1 trials can help in predicting response to medications and improve drug development for rare conditions.

Pi is important because it represents the idea of infinity and the beauty found in mathematics. It has endless digits that seem random, showing a unique balance between order and chaos.
Voice technology is booming in the tech world, with devices like Amazon's Echo leading the charge. This shift brings both opportunities and challenges for developers and users.
Data science is becoming more accessible with practical examples and applications emerging in real-world scenarios. Companies are using data science to improve their products and daily operations.

The spread of diseases like COVID-19 can become very rapid if not controlled properly. Understanding how infections spread helps us take the right actions.
There are tools and models that can help track COVID-19 cases in real time, which is important for managing outbreaks effectively.
New techniques in data science, like reinforcement learning and efficient neural networks, are enhancing how we analyze and work with data in various fields.

Good communication can help teams solve technical problems better and make a bigger impact on their work.
There are exciting competitions, like the C3.ai COVID-19 Grand Challenge, where data science projects can help tackle global issues.
New tools like TensorFlow Recommenders and platforms like Dynabench are making it easier to build AI and benchmark its performance effectively.

FDA authorized the first over-the-counter continuous glucose monitor (CGM), Dexcom Stelo Glucose Biosensor System, for individuals 18 and older not using insulin.
The CGM system aims to help users understand the effects of diet and exercise on blood sugar levels, providing glucose readings every 15 minutes with sensors lasting up to 15 days.
The FDA clearance for this device emphasizes increased health equity by making health monitoring more accessible, although some side effects like skin irritation and pain have been reported.